Astera Labs, Inc. (NASDAQ:ALAB) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of Astera Labs, Inc. (NASDAQ:ALAB) have earned an average rating of “Moderate Buy” from the twenty-one analysts that are presently covering the firm, MarketBeat.com reports. Nine research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $348.33.

A number of brokerages have recently commented on ALAB. Weiss Ratings restated a “hold (c)” rating on shares of Astera Labs in a report on Tuesday, August 18th. Needham & Company LLC boosted their price objective on shares of Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a research note on Wednesday, August 5th. Roth Capital restated a “buy” rating and issued a $450.00 price objective on shares of Astera Labs in a report on Wednesday, August 5th. Bank of America upped their price objective on shares of Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a report on Tuesday, June 23rd. Finally, Stifel Nicolaus lifted their target price on shares of Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a report on Wednesday, June 24th.

Insider Buying and Selling

In related news, Director Manuel Alba sold 183,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total transaction of $51,263,790.00. Following the completion of the transaction, the director owned 253,863 shares of the company’s stock, valued at $71,114,642.19. This trade represents a 41.89% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 6,801 shares of Astera Labs stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.50, for a total value of $2,315,740.50. Following the transaction, the general counsel owned 96,542 shares of the company’s stock, valued at $32,872,551. The trade was a 6.58% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 396,059 shares of company stock worth $122,605,660 over the last three months. Corporate insiders own 10.40% of the company’s stock.

Hedge Funds Weigh In On Astera Labs

Large investors have recently modified their holdings of the stock. Farther Finance Advisors LLC boosted its stake in Astera Labs by 102.8% in the 3rd quarter. Farther Finance Advisors LLC now owns 6,043 shares of the company’s stock worth $2,151,000 after purchasing an additional 3,063 shares in the last quarter. CoreCap Advisors LLC increased its stake in Astera Labs by 21.0% during the 3rd quarter. CoreCap Advisors LLC now owns 749 shares of the company’s stock valued at $267,000 after purchasing an additional 130 shares in the last quarter. Cooper Financial Group bought a new stake in Astera Labs during the 3rd quarter valued at about $203,000. MRA Advisory Group raised its holdings in Astera Labs by 19.6% in the third quarter. MRA Advisory Group now owns 4,299 shares of the company’s stock worth $1,530,000 after buying an additional 705 shares during the last quarter. Finally, QRG Capital Management Inc. lifted its stake in shares of Astera Labs by 8.7% in the second quarter. QRG Capital Management Inc. now owns 4,775 shares of the company’s stock worth $2,306,000 after buying an additional 381 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Stock Performance

ALAB opened at $347.05 on Friday. The stock has a market capitalization of $60.21 billion, a PE ratio of 171.81 and a beta of 3.68. The stock’s 50 day moving average price is $316.82 and its 200-day moving average price is $290.03. Astera Labs has a 52-week low of $97.89 and a 52-week high of $499.48.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The company had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. During the same quarter last year, the firm posted $0.44 earnings per share. The firm’s revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Research analysts forecast that Astera Labs will post 2.7 EPS for the current fiscal year.

Astera Labs Company Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.